Temporal analysis of mRNA and miRNA expression in transgenic mice overexpressing Arg- and Gly389 polymorphic variants of the β1-adrenergic receptor

被引:15
作者
Dockstader, Karen [1 ]
Nunley, Karin [1 ]
Karimpour-Fard, Anis [2 ]
Medway, Allen [1 ]
Nelson, Penny [1 ]
Port, J. David [1 ]
Liggett, Stephen B. [3 ]
Bristow, Michael R. [1 ]
Sucharov, Carmen C. [1 ]
机构
[1] Univ Colorado, Sch Med, Div Cardiol, Aurora, CO USA
[2] Univ Colorado, Sch Med, Ctr Computat Pharmacol, Aurora, CO USA
[3] Univ Maryland, Sch Med, Cardiopulm Genom Program, Baltimore, MD 21201 USA
关键词
Ca2+/calmodulin-dependent protein kinase; signal transduction; genetic polymorphism; HEART-FAILURE; MYOCARDIAL-INFARCTION; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; CARDIAC-HYPERTROPHY; MICRORNA EXPRESSION; PHOSPHORYLATION; CARDIOMYOPATHY; ACTIVATION; SIGNATURE;
D O I
10.1152/physiolgenomics.00067.2011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Dockstader K, Nunley K, Karimpour-Fard A, Medway A, Nelson P, Port JD, Liggett SB, Bristow MR, Sucharov CC. Temporal analysis of mRNA and miRNA expression in transgenic mice overexpressing Arg- and Gly389 polymorphic variants of the beta(1)-adrenergic receptor. Physiol Genomics 43: 1294-1306, 2011. First published September 27, 2011; doi:10.1152/physiolgenomics.00067.2011.-Several studies in humans or transgenic animals have reported that the 389 Arg or Gly polymorphic variation of the beta(1)-adrenergic receptor (AR) is associated with differential responses to beta-blocker therapy and/or myocardial disease progression. Analysis of changes in gene expression is an important means of defining molecular differences associated with structural or functional phenotypic variations. To determine if structural and functional myocardial phenotypic differences between beta(1)389 Arg vs. Gly transgenic overexpressors are associated with qualitative and/or quantitative differences in gene expression, a comprehensive analysis of mRNAs and miRNAs expressed in the hearts of 3 and 6-8 mo old beta(1)-Arg389 and beta(1)-Gly389 overexpressor transgenic mice was performed. Changes in mRNA and miRNA expression were analyzed by arrays and partially confirmed by RT-qPCR. Bioinformatic analysis demonstrated that several genes, including those involved in PKA and CaMK signaling pathways, are regulated in a temporal-or phenotype-specific manner. Furthermore, expression signature analyses indicated that miRNAs have the potential to target expression of a number of genes involved in multiple cardiomyopathy-related pathways, and changes in miRNA expression can precede the onset of disease. Differences in gene expression between beta(1)-Arg389 and beta(1)-Gly389 transgenic mice are largely quantitative rather than qualitative and are associated with the development of cardiomyopathy in a time-dependent manner. Chronic beta(1)-AR overdrive results in increased expression of components of the CaMK pathway, with correspondingly decreased levels of components of the PKA pathway. Based on the temporal and genotype-specific pattern of miRNA expression, miRNAs are likely to be important predictors of disease states, especially when miRNA expression is paired with mRNA expression, and that miRNA/mRNA expression signatures have the potential to be useful in determining the underlying risk associated with cardiac disease progression.
引用
收藏
页码:1294 / 1306
页数:13
相关论文
共 37 条
[21]   Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure [J].
Port, JD ;
Bristow, MR .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (05) :887-905
[22]   MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue [J].
Roy, Sashwati ;
Khanna, Savita ;
Hussain, Syed-Rehan A. ;
Biswas, Sabyasachi ;
Azad, Ali ;
Rink, Cameron ;
Gnyawali, Surya ;
Shilo, Shani ;
Nuovo, Gerard J. ;
Sen, Chandan K. .
CARDIOVASCULAR RESEARCH, 2009, 82 (01) :21-29
[23]   MicroRNAs Add a New Dimension to Cardiovascular Disease [J].
Small, Eric M. ;
Frost, Robert J. A. ;
Olson, Eric N. .
CIRCULATION, 2010, 121 (08) :1022-U66
[24]   YY1 Protects Cardiac Myocytes from Pathologic Hypertrophy by Interacting with HDAC5 [J].
Sucharov, Carmen C. ;
Dockstader, Karen ;
McKinsey, Timothy A. .
MOLECULAR BIOLOGY OF THE CELL, 2008, 19 (10) :4141-4153
[25]   A β1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction [J].
Sucharov, Carmen C. ;
Mariner, Peter D. ;
Nunley, Karin R. ;
Long, Carlin ;
Leinwand, Leslie ;
Bristow, Michael R. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (03) :H1299-H1308
[26]   β-Adrenergic Receptor Stimulation and Activation of Protein Kinase A Protect Against α1-Adrenergic-Mediated Phosphorylation of Protein Kinase D and Histone Deacetylase 5 [J].
Sucharov, Carmen C. ;
Dockstader, Karen ;
Nunley, Karin ;
McKinsey, Timothy A. ;
Bristow, Michael .
JOURNAL OF CARDIAC FAILURE, 2011, 17 (07) :592-600
[27]   Differential coupling of Arg- and Gly389 polymorphic forms of the β1-adrenergic receptor leads to pathogenic cardiac gene regulatory programs [J].
Swift, Steven M. ;
Gaume, Brigitte R. ;
Small, Kersten M. ;
Aronow, Bruce J. ;
Liggett, Stephen B. .
PHYSIOLOGICAL GENOMICS, 2008, 35 (01) :123-131
[28]   Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase:: Enhanced basal catalytic activity and function without increased cardiomyocyte β-adrenergic signalling [J].
Tepe, NM ;
Lorenz, JN ;
Yatani, A ;
Dash, R ;
Kranias, EG ;
Dorn, GW ;
Liggett, SB .
BIOCHEMISTRY, 1999, 38 (50) :16706-16713
[29]  
Terra Steven G, 2005, Pharmacogenet Genomics, V15, P227, DOI 10.1097/01213011-200504000-00006
[30]   Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis [J].
van Rooij, Eva ;
Sutherland, Lillian B. ;
Thatcher, Jeffrey E. ;
DiMaio, J. Michael ;
Naseem, R. Haris ;
Marshall, William S. ;
Hill, Joseph A. ;
Olson, Eric N. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (35) :13027-13032